White Jonathan

Average Profitability
3.73%
Insider Buys Quantity
7
Insider Buys Sum
$370,557.20
Insider Sells Quantity
5
Insider Sells Sum
$505,814.62

Insider Activity of White Jonathan

The largest purchase of all time was on 2009-03-04 and amounted to 3000 shares of Haemonetics Corporation for $160,478.

The largest sale of all time was on 2013-02-26 and amounted to 6000 shares of Haemonetics Corporation for $244,140.

Biography of White Jonathan

No biography is available at this moment.

2015-10-26SaleHaemonetics Corporation
HAE
Chief Science and Technology
319
0.0006%
$32.13$10,249+0.8%
2015-10-23SaleHaemonetics Corporation
HAE
Chief Science and Technology
250
0.0005%
$31.75$7,937+1.59%
2015-07-02SaleHaemonetics Corporation
HAE
Chief Science and Technology
2,385
0.0048%
$41.14$98,119-19%
2014-02-07SaleHaemonetics Corporation
HAE
Chief Science and Technology
3,760
0.0073%
$38.66$145,369-6.94%
2013-04-30PurchaseHaemonetics Corporation
HAE
Chief Scientific and Technogy
1,230
0.002%
$32.73$40,252+5.27%
2013-02-26SaleHaemonetics Corporation
HAE
VP Research and Development
6,000
0.0117%
$40.69$244,140+0.47%
2012-05-01PurchaseHaemonetics Corporation
HAE
VP Research and Development
852
0.0023%
$49.83$42,453+10.48%
2011-05-04PurchaseHaemonetics Corporation
HAE
VP Research and Development
910
0.0025%
$46.80$42,589-4.87%
2010-11-04PurchaseHaemonetics Corporation
HAE
VP Research and Development
8
<0.0001%
$46.34$371+6.76%
2010-04-30PurchaseHaemonetics Corporation
HAE
VP Research and Development
920
0.0029%
$45.70$42,048+0.05%
2009-10-30PurchaseHaemonetics Corporation
HAE
VP Research and Development
960
0.0033%
$44.13$42,367+6.8%
2009-03-04PurchaseHaemonetics Corporation
HAE
VP Research and Development
3,000
0.0118%
$53.49$160,478+1.61%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.